- ·The complete investor list: 22 names
- ·Watch IMBiologics (KRX: 493280): the Monday email on marks, rounds and moves
IMBiologics (KRX: 493280) funding history
No funding rounds for IMBiologics (KRX: 493280) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
IMBiologics (KRX: 493280) valuation
IMBiologics (KRX: 493280) is now publicly traded; this page covers its private-market history, where its last recorded valuation was $262 million (Mar 2026). Secondary trades, fund marks and rounds below are the private-market record; the listed share price is not tracked here.
How IMBiologics (KRX: 493280)'s valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For IMBiologics (KRX: 493280), too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about IMBiologics (KRX: 493280)
- What is IMBiologics (KRX: 493280) worth?
- IMBiologics (KRX: 493280)'s last known valuation is $261.7M.
- How much has IMBiologics (KRX: 493280) raised?
- IMBiologics (KRX: 493280) has raised $99.1M in total funding across its recorded rounds.